InvestorsHub Logo
Followers 9
Posts 682
Boards Moderated 0
Alias Born 03/11/2013

Re: None

Tuesday, 03/07/2023 12:49:56 PM

Tuesday, March 07, 2023 12:49:56 PM

Post# of 429264
The one big change AD and Sarissa brings to the table is moving away from the nonsensical GIA rhetoric. The old board always thought GIA is the best value creation for shareholders when all shareholders wanted from this one drug company was it to be sold to a BP who can implement Vascepa successfully. There was such a huge disconnect between the shareholders and the management at Amarin that it just boggles the mind. Time is of essence. Everyday we dont do anything we are potentially losing millions of dollars in lost opportunity costs as patent clocks in EU run out. There needs to be a sense of urgency to quickly make changes and chare the plan of action with us. 2 Years to see this company is way too long as that translates to 100's of millions of dollars in lost revenues that could be achieved by some strong BP. Whatever needs to happen in my opinion, will happen in the next 6-8 months. Tick tock. Exciting times ahead, finally.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News